State of New Jersey Common Pension Fund D’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$941K Sell
37,211
-3,262
-8% -$71.8K ﹤0.01% 1552
2026
Q1
$901K Buy
40,473
+164
+0.4% +$3.92K ﹤0.01% 1409
2025
Q4
$1.08M Sell
40,309
-45,512
-53% -$1.09M ﹤0.01% 1392
2025
Q3
$1.83M Buy
+85,821
New +$2.03M 0.01% 1396
2024
Q2
Sell
-112,270
Closed -$2.08M 1517
2024
Q1
$2.08M Hold
112,270
0.01% 1510
2023
Q4
$3.52M Buy
112,270
+19,703
+21% +$471K 0.01% 833
2023
Q3
$1.93M Sell
92,567
-9,383
-9% -$255K 0.01% 1542
2023
Q2
$2.44M Sell
101,950
-20,492
-17% -$455K 0.01% 1388
2023
Q1
$2.3M Sell
122,442
-32,845
-21% -$626K 0.01% 1190
2022
Q4
$2.47M Buy
155,287
+10,073
+7% +$157K 0.01% 1015
2022
Q3
$2.38M Buy
145,214
+12,443
+9% +$202K 0.01% 989
2022
Q2
$1.87M Buy
132,771
+36,129
+37% +$674K 0.01% 1583
2022
Q1
$2.34M Sell
96,642
-50,023
-34% -$1.21M 0.01% 1508
2021
Q4
$3.42M Sell
146,665
-16,460
-10% -$331K 0.01% 939
2021
Q3
$2.71M Buy
163,125
+46,888
+40% +$904K 0.01% 1291
2021
Q2
$2.83M Buy
116,237
+37,038
+47% +$836K 0.01% 1124
2021
Q1
$2.04M Sell
79,199
-2,636
-3% -$116K 0.01% 1548
2020
Q4
$4.38M Sell
81,835
-3,786
-4% -$188K 0.02% 779
2020
Q3
$3.53M Sell
85,621
-98
-0.1% -$4.23K 0.01% 800
2020
Q2
$4.16M Buy
85,719
+6,094
+8% +$293K 0.02% 711
2020
Q1
$3.36M Hold
79,625
0.02% 744
2019
Q4
$3.41M Sell
79,625
-12,375
-13% -$538K 0.01% 934
2019
Q3
$3.31M Buy
+92,000
New +$2.79M 0.01% 964

Other funds holding ACAD

State of New Jersey Common Pension Fund D's ACAD Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Acadia Pharmaceuticals (ACAD) stake by 8.1% in Q2 2026, selling an estimated $71.8K and leaving 37,211 shares worth $941K. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

State of New Jersey Common Pension Fund D first reported a position in ACAD in Q3 2019 and has held it in 23 quarters since. The position peaked at $4.38M in Q4 2020. 175 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 37,211 shares of Acadia Pharmaceuticals worth $941K as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 3,262 Acadia Pharmaceuticals shares in Q2 2026, an estimated $71.8K.
  • Acadia Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1552 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Acadia Pharmaceuticals in Q3 2019 and has held it in 23 quarters since.
  • State of New Jersey Common Pension Fund D's Acadia Pharmaceuticals position peaked at $4.38M in Q4 2020.
  • 175 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.